Editors: Gene D. Morse, Sarah Nanzigu

Series Title: Frontiers in HIV Research

Advances in HIV Treatment: HIV Enzyme Inhibitors and Antiretroviral Therapy

Volume 1

eBook: US $39 Special Offer (PDF + Printed Copy): US $106
Printed Copy: US $87
Library License: US $156
ISSN: 2405-9862 (Print)
ISSN: 2405-9889 (Online)
ISBN: 978-1-68108-057-4 (Print)
ISBN: 978-1-68108-056-7 (Online)
Year of Publication: 2015
DOI: 10.2174/97816810805671150101

Introduction

Advances in HIV Treatment: HIV Enzyme Inhibitors and Antiretroviral Therapy presents comprehensive and updated information on drug therapies used to treat and manage HIV infection in human patients. The volume is organized in to chapters detailing respective classes of HIV Drugs including HIV entry inhibitors, reverse transcriptase inhibitors (RTIs), integrase strand inhibitors (INSTIs), and protease inhibitors (PIs). Each chapter compiles background information, pharmacology and clinical aspects such as side effects on the specific classes of drugs represented. Available data for ongoing research for new targets, including vaccines is also presented. Readers will also find a useful introduction to HIV virology and pathogenesis as well as a comparison of the availability and activity of these agents in different populations, opening a discussion on the influence of genetics and resources in curbing the HIV epidemic. Advances in HIV Treatment: HIV Enzyme Inhibitors and Antiretroviral Therapy is, therefore, a holistic resource for researchers, healthcare professionals and clinicians interested in understanding antiretroviral drugs and the management of HIV infection/AIDS. The volume is also of interest to undergraduate and graduate students undertaking specialized courses in pharmacology and HIV/AIDS management.

Foreword

- Pp. i
Charles Chiedza Maponga
Download Free

Preface

- Pp. ii
Gene D. Morse, Sarah Nanzigu
Download Free

List of Contributors

- Pp. iii
Gene D. Morse, Sarah Nanzigu
Download Free

Acknowledgements

- Pp. iv
Gene D. Morse, Sarah Nanzigu
Download Free

Introduction

- Pp. 3-22 (20)
Sarah Nanzigu, Francis Xavier Kasujja, Immaculate Nankya
View Abstract

HIV-1 Entry Inhibitors

- Pp. 23-43 (21)
Joshua R. Sawyer, Charles S. Venuto, Gene D. Morse
View Abstract

Reverse Transcriptase Inhibitors

- Pp. 44-61 (18)
Amy Moss, Cara Felton, Sarah Nanzigu
View Abstract

Integrase Inhibitors

- Pp. 62-74 (13)
Sarah Nanzigu, Francis Xavier Kasujja
View Abstract

Protease Enzyme Inhibition

- Pp. 75-96 (22)
Rebecca A. Sumner, Cindy J. Bednasz, Qing Ma, Gene D. Morse
View Abstract

Pharmacogenomics and Antiretroviral Therapy: Pharmacogenomics of HIV-1 Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors - Implications for Personalized Antiretroviral Therapy

- Pp. 97-114 (18)
Qing Ma, Kevin Hsu, Gene D. Morse
View Abstract

HIV Co-Treatment

- Pp. 115-135 (21)
Sarah Nanzigu, Jaran Eriksen, Pauline Byakika-Kibwika
View Abstract

Demographic Influence on the Evolution of Antiretroviral Therapy (ART)

- Pp. 136-153 (18)
Sarah Nanzigu, Moses R. Kamya, Gene D. Morse
View Abstract

Subject Index

- Pp. 154-160 (7)
Gene D. Morse, Sarah Nanzigu
Download Free

RELATED BOOKS

.An Update on SARS-CoV-2: Damage-response Framework, Potential Therapeutic Avenues and the Impact of Nanotechnology on COVID-19 Therapy.
.COVID-19: Effects in Comorbidities and Special Populations.
.Current Developments in the Detection and Control of Multi Drug Resistance.
.Moving From COVID-19 Mathematical Models to Vaccine Design: Theory, Practice and Experiences.